Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 7/20 | 0.37 |
| ▸ | ESR1 | P03372 | 6/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19081914 | 0.90 | ESR2 (0.35) | ESR2ESR1LIMK1PRKDCCYP1A1 | |
| SCHEMBL19076742 | 0.88 | ESR2 (0.38) | ESR2ESR1PRKDCCYP1A1CYP1B1 | |
| SCHEMBL19081769 | 0.88 | ESR2 (0.35) | ESR2ESR1LIMK1PLA2G2APLA2G4A | |
| SCHEMBL19080198 | 0.84 | CYP1A1 (0.34) | ESR2ESR1PRKDCCYP1A1CYP1B1 | |
| SCHEMBL19076672 | 0.84 | ALOX5 (0.34) | ESR2ESR1LIMK1PLA2G10PLA2G2A | |
| SCHEMBL19081509 | 0.84 | PLA2G2A (0.41) | ESR2ESR1PRKDCPLA2G10PLA2G2A | |
| SCHEMBL19082226 | 0.84 | ESR1 (0.39) | ESR2ESR1LIMK1CYP1A1CYP1B1 | |
| SCHEMBL19076891 | 0.83 | S1PR5 (0.37) | ESR2ESR1PRKDCCYP1A1CYP1B1 | |
| SCHEMBL21579275 | 0.83 | CYP1B1 (0.35) | LIMK1PLA2G10PLA2G2APLA2G4ACYP1A1 | |
| SCHEMBL19076975 | 0.83 | PRKDC (0.34) | ESR2ESR1PRKDCALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNT1 | ESR2 542/4885ESR1 225/4885LIMK1 440/4885 |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | ESR2 542/4885ESR1 225/4885LIMK1 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.